In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cocrystal Pharma Inc. (OTCBB:COCP) reported that Opko Health, Inc. has picked up 63,634,259 of common stock as of 2017-05-10.
The acquisition brings the aggregate amount owned by Opko Health, Inc. to a total of 63,634,259 representing less than 8.7% stake in the company.
For those not familiar with the company, Cocrystal Pharma, Inc., formerly Biozone Pharmaceuticals, Inc., is engaged in developing medicines for use in the treatment of human viral diseases. The Company develops technologies and approaches to create antiviral drug candidates. The Company is developing antiviral therapeutics that inhibit the replication function of a virus, including the ribonucleic acid (RNA)-dependent RNA polymerase enzyme, the helicase enzyme and the NS5A protein of hepatitis C virus (HCV), and the polymerase enzymes of influenza virus and norovirus. The polymerase inhibitors include both nucleosides (Nucs) and non-nucleosides. Its platform consists of computation, medicinal chemistry, click chemistry and X-ray crystallography. The Company determines the structures of cocrystals containing the inhibitors bound to the enzyme or protein to guide its design. The Company uses computational methods to screen and design product candidates using its cocrystal structural information.
A glance at Cocrystal Pharma Inc. (OTCBB:COCP)’s key stats reveals a current market capitalization of 156.50 Million based on 727.00 Million shares outstanding and a price at last close of $0.252 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-09-01, Block picked up 10,000 at a purchase price of $0.41. This brings their total holding to 168,696 as of the date of the filing.
On the sell side, the most recent transaction saw Lee unload 2,200,000 shares at a sale price of $0.44. This brings their total holding to 13,087,847.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cocrystal Pharma Inc. (OTCBB:COCP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.